Werawatganon T, Charuluxanun S
Anaesthesiology, Faculty of Medicine, Chulalongkorn University, Rama 4, Pathumwan, Bangkok, Thailand, 10330.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004088. doi: 10.1002/14651858.CD004088.pub2.
There are two common techniques for postoperative pain control after intra-abdominal surgery: patient-controlled analgesia (PCA) with intravenous opioids and continuous epidural analgesia (CEA). It is uncertain which method has better pain control and fewer adverse effects.
The objective of this review was to compare PCA opioid therapy with CEA for pain control after intra-abdominal surgery in terms of analgesic efficacy, side effects, patient satisfaction and surgical outcome by meta-analysis of the relevant trials.
We searched CENTRAL (The Cochrane Library Issue 4, 2002), MEDLINE (January 1966 to October 2002), EMBASE (January 1988 to October 2002), and reference lists of articles. We also contacted researchers in the field.
Randomized controlled trials of adult patients after intra-abdominal surgery comparing the effect of two pain control regimens in terms of analgesic efficacy and side effects. In the patient-controlled analgesia (PCA) group the patient should be able to operate the device himself. In the continuous epidural analgesia group there was no PCA device.
Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for additional information. Adverse effects information was collected from the trials.
Nine studies involving 711 participants were included. The PCA group had a higher pain visual analogue scale than the CEA group during 6, 24 and 72 hour periods. The weighted mean difference and 95% confidence interval of resting pain was 1.74 (95% CI 1.30 to 2.19), 0.99 (95% CI 0.65 to 1.33), and 0.63 (95% CI 0.24 to 1.01), respectively. The length of hospital stay and other adverse effects were not statistically different except that the incidence of pruritus was lower in the PCA group, odds ratio of 0.27 (95% CI 0.11 to 0.64).
AUTHORS' CONCLUSIONS: CEA is superior to opioid PCA in relieving postoperative pain for up to 72 hours in patients undergoing intra-abdominal surgery, but it is associated with a higher incidence of pruritus. There is insufficient evidence to draw comparisons about the other advantages and disadvantages of these two methods of pain relief.
腹部手术后术后疼痛控制有两种常用技术:静脉注射阿片类药物的患者自控镇痛(PCA)和持续硬膜外镇痛(CEA)。尚不确定哪种方法具有更好的疼痛控制效果和更少的不良反应。
本综述的目的是通过对相关试验的荟萃分析,比较PCA阿片类药物疗法与CEA在腹部手术后疼痛控制方面的镇痛效果、副作用、患者满意度和手术结局。
我们检索了Cochrane中心对照试验注册库(CENTRAL,2002年第4期)、医学文献数据库(MEDLINE,1966年1月至2002年10月)、荷兰医学文摘数据库(EMBASE,1988年1月至2002年10月)以及文章的参考文献列表。我们还联系了该领域的研究人员。
比较两种疼痛控制方案在镇痛效果和副作用方面的腹部手术后成年患者的随机对照试验。在患者自控镇痛(PCA)组中,患者应能够自行操作设备。在持续硬膜外镇痛组中,没有PCA设备。
两名评价员独立评估试验质量并提取数据。与研究作者联系以获取更多信息。从试验中收集不良反应信息。
纳入了9项涉及711名参与者的研究。在术后6小时、24小时和72小时期间,PCA组的疼痛视觉模拟评分高于CEA组。静息痛的加权平均差和95%置信区间分别为1.74(95%CI 1.30至2.19)、0.99(95%CI 0.65至1.33)和0.63(95%CI 0.24至1.01)。住院时间和其他不良反应在统计学上无差异,除了PCA组瘙痒发生率较低,比值比为0.27(95%CI 0.11至0.64)。
对于接受腹部手术的患者,CEA在缓解术后疼痛长达72小时方面优于阿片类药物PCA,但它与较高的瘙痒发生率相关。没有足够的证据对这两种疼痛缓解方法的其他优缺点进行比较。